HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Phillip Koeffler Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

8/2008Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.
10/2006DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML.
11/2005Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome.
4/2002Differentiation therapy for myelodysplastic syndrome.
2/2002Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Phillip Koeffler Research Topics

Disease

149Neoplasms (Cancer)
03/2024 - 01/2002
31Leukemia
11/2017 - 02/2002
23Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 02/2002
22Breast Neoplasms (Breast Cancer)
01/2022 - 09/2002
20Prostatic Neoplasms (Prostate Cancer)
12/2023 - 07/2002
16Carcinogenesis
11/2022 - 02/2002
14Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2003
13Hematologic Neoplasms (Hematological Malignancy)
10/2015 - 05/2002
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2017 - 03/2002
11Multiple Myeloma
01/2022 - 03/2002
11Glioma (Gliomas)
01/2020 - 11/2002
10Myeloid Leukemia (Leukemia, Myelocytic)
01/2021 - 02/2003
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015 - 02/2004
9Acute Promyelocytic Leukemia
01/2021 - 10/2003
9Lung Neoplasms (Lung Cancer)
01/2019 - 01/2002
9Lymphoma (Lymphomas)
08/2012 - 05/2002
7Liposarcoma
11/2022 - 01/2003
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 08/2007
7Brain Neoplasms (Brain Tumor)
01/2018 - 11/2002
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2010 - 05/2002
6Hemochromatosis (Bronze Diabetes)
01/2016 - 08/2002
6Infections
02/2015 - 03/2008
6Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2008 - 05/2004
6Endometrial Neoplasms (Endometrial Cancer)
03/2007 - 02/2004
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 09/2010
5Adenocarcinoma
01/2023 - 02/2009
5Hepatocellular Carcinoma (Hepatoma)
01/2017 - 09/2014
5Hypercalcemia (Milk Alkali Syndrome)
01/2014 - 11/2002
5Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2009 - 02/2003
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2009 - 03/2003
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2008 - 02/2002
4Ovarian Neoplasms (Ovarian Cancer)
04/2023 - 10/2005
4Esophageal Squamous Cell Carcinoma
10/2020 - 03/2007
4Osteosarcoma (Osteogenic Sarcoma)
01/2018 - 01/2002
4B-Cell Lymphoma (Lymphoma, B Cell)
08/2013 - 03/2007
4Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2009 - 05/2002
4Genetic Translocation (Chromosomal Translocation)
10/2007 - 05/2002
4Blast Crisis (Blast Phase)
09/2007 - 12/2003
4Philadelphia Chromosome
05/2006 - 02/2002
3Carcinoma (Carcinomatosis)
04/2023 - 12/2004
3Hypoxia (Hypoxemia)
01/2021 - 09/2014
3Ewing Sarcoma (Sarcoma, Ewing)
11/2020 - 01/2016
3Melanoma (Melanoma, Malignant)
01/2019 - 09/2002

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2002
26DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2002
20Transcription Factors (Transcription Factor)IBA
10/2023 - 02/2002
18Messenger RNA (mRNA)IBA
01/2020 - 02/2002
15Histone Deacetylase InhibitorsIBA
01/2019 - 02/2004
14Phosphotransferases (Kinase)IBA
01/2018 - 01/2002
12LigandsIBA
09/2015 - 01/2003
12AndrogensIBA
05/2012 - 07/2002
11Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2021 - 06/2003
11CCAAT-Enhancer-Binding Protein-alphaIBA
08/2012 - 02/2002
9Tyrosine Kinase InhibitorsIBA
01/2018 - 02/2002
9Vitamin DFDA LinkGeneric
01/2013 - 02/2002
8Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2007
8RNA (Ribonucleic Acid)IBA
01/2023 - 06/2008
8Small Interfering RNA (siRNA)IBA
01/2022 - 10/2005
8cucurbitacin BIBA
06/2013 - 09/2008
8NF-kappa B (NF-kB)IBA
02/2008 - 12/2003
7Calcitriol (Calcijex)FDA LinkGeneric
01/2014 - 03/2002
7Androgen Receptors (Androgen Receptor)IBA
10/2009 - 11/2003
7VorinostatFDA Link
02/2009 - 01/2005
7Imatinib Mesylate (Gleevec)FDA Link
08/2008 - 02/2002
7PPAR gammaIBA
01/2008 - 01/2003
7herbal preparation PC-SPESIBA
09/2007 - 09/2002
6Proteasome InhibitorsIBA
02/2021 - 02/2004
6Bortezomib (Velcade)FDA Link
02/2021 - 02/2004
61,25-dihydroxyvitamin DIBA
05/2012 - 06/2003
5selinexorIBA
02/2021 - 09/2014
5Histones (Histone)IBA
01/2018 - 01/2006
5EnzymesIBA
08/2017 - 08/2006
5CytokinesIBA
02/2015 - 12/2003
5TriterpenesIBA
06/2013 - 10/2004
5Connective Tissue Growth FactorIBA
06/2011 - 10/2005
5OligonucleotidesIBA
09/2010 - 05/2004
5TOR Serine-Threonine KinasesIBA
08/2010 - 10/2006
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023 - 10/2006
4ChromatinIBA
01/2021 - 01/2005
4hydroxide ionIBA
01/2020 - 10/2005
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 06/2008
4Histone Deacetylases (Histone Deacetylase)IBA
03/2018 - 08/2007
4Cyclin D1IBA
01/2018 - 03/2003
4IronIBA
01/2016 - 08/2002
4GemcitabineFDA Link
09/2014 - 07/2009
4Cysteine (L-Cysteine)FDA Link
01/2014 - 08/2005
4Prostate-Specific Antigen (Semenogelase)IBA
05/2012 - 11/2003
4AgarIBA
11/2010 - 02/2004
4Cholecalciferol (Vitamin D3)FDA Link
11/2008 - 11/2002
4Human immunodeficiency virus 1 p16 proteaseIBA
08/2006 - 04/2004
4Transferrin Receptors (Transferrin Receptor)IBA
08/2005 - 02/2002
3InterferonsIBA
03/2024 - 01/2019
3Proteasome Endopeptidase Complex (Proteasome)IBA
02/2021 - 03/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020 - 07/2003
3Oncogene Proteins (Oncogene Protein)IBA
01/2019 - 03/2007
3PanobinostatIBA
01/2019 - 09/2013

Therapy/Procedure

53Therapeutics
03/2024 - 04/2002
9Drug Therapy (Chemotherapy)
01/2021 - 02/2003
5Aftercare (After-Treatment)
01/2017 - 09/2002
3Immunotherapy
01/2023 - 01/2019